MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD. Financials Meinian Onehealth Healthcare Holdings Co., Ltd.
Equities
002044
CNE000001LV7
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.81 CNY | +5.02% |
|
+5.25% | -19.97% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 58,014 | 44,079 | 30,540 | 23,849 | 23,382 | 18,713 | - |
| Enterprise Value (EV) 1 | 60,430 | 45,933 | 30,540 | 23,849 | 23,382 | 18,713 | 18,713 |
| P/E ratio | -64.7 x | 80.9 x | 393 x | -43.8 x | 46.2 x | 22.6 x | 16.8 x |
| Yield | 0.36% | - | - | - | - | - | - |
| Capitalization / Revenue | 6.81 x | 5.64 x | 3.34 x | - | 2.15 x | 1.58 x | 1.4 x |
| EV / Revenue | 6.81 x | 5.64 x | 3.34 x | - | 2.15 x | 1.58 x | 1.4 x |
| EV / EBITDA | 223 x | 28.9 x | 28.8 x | - | 15.5 x | 9.99 x | 8.85 x |
| EV / FCF | - | 62,176,523 x | 18,621,590 x | - | - | - | - |
| FCF Yield | - | 0% | 0% | - | - | - | - |
| Price to Book | 7.98 x | 5.56 x | 3.82 x | - | 3.06 x | 2.14 x | 1.92 x |
| Nbr of stocks (in thousands) | 3,896,148 | 3,890,481 | 3,890,481 | 3,890,481 | 3,890,481 | 3,890,481 | - |
| Reference price 2 | 14.89 | 11.33 | 7.850 | 6.130 | 6.010 | 4.810 | 4.810 |
| Announcement Date | 4/14/20 | 4/12/21 | 4/15/22 | 4/24/23 | 4/24/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 8,525 | 7,815 | 9,156 | - | 10,894 | 11,869 | 13,380 |
| EBITDA 1 | 260.4 | 1,526 | 1,061 | - | 1,507 | 1,873 | 2,115 |
| EBIT 1 | -448.8 | 828.6 | 391.2 | - | 883.7 | 1,109 | 1,480 |
| Operating Margin | -5.26% | 10.6% | 4.27% | - | 8.11% | 9.34% | 11.06% |
| Earnings before Tax (EBT) 1 | -485.7 | 783.9 | 366.1 | - | 848.1 | 1,078 | 1,440 |
| Net income 1 | -866.5 | 554 | 64.14 | -533.1 | 505.6 | 840.1 | 1,119 |
| Net margin | -10.16% | 7.09% | 0.7% | - | 4.64% | 7.08% | 8.36% |
| EPS 2 | -0.2300 | 0.1400 | 0.0200 | -0.1400 | 0.1300 | 0.2125 | 0.2867 |
| Free Cash Flow | - | 708.9 | 1,640 | - | - | - | - |
| FCF margin | - | 9.07% | 17.91% | - | - | - | - |
| FCF Conversion (EBITDA) | - | 46.46% | 154.55% | - | - | - | - |
| FCF Conversion (Net income) | - | 127.98% | 2,557.14% | - | - | - | - |
| Dividend per Share | 0.0529 | - | - | - | - | - | - |
| Announcement Date | 4/14/20 | 4/12/21 | 4/15/22 | 4/24/23 | 4/24/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|
| Net sales 1 | - | 2,310 | 2,812 | 3,676 |
| EBITDA | - | - | - | - |
| EBIT | - | - | - | - |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - |
| Net income | -167.2 | - | - | - |
| Net margin | - | - | - | - |
| EPS | -0.0400 | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 4/27/23 | 8/29/23 | 10/30/23 | 4/24/24 |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | 2,416 | 1,854 | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 9.279 x | 1.215 x | - | - | - | - | - |
| Free Cash Flow | - | 709 | 1,640 | - | - | - | - |
| ROE (net income / shareholders' equity) | -13.8% | 7.23% | 0.8% | - | 6.64% | 9.45% | 11.4% |
| ROA (Net income/ Total Assets) | -4.91% | 2.97% | 0.34% | - | - | 3.9% | 4.73% |
| Assets 1 | 17,636 | 18,626 | 18,606 | - | - | 21,541 | 23,644 |
| Book Value Per Share 2 | 1.870 | 2.040 | 2.050 | - | 1.970 | 2.250 | 2.510 |
| Cash Flow per Share 2 | 0.3200 | 0.2500 | 0.5300 | - | 0.5200 | 0.4900 | 0.4700 |
| Capex 1 | 429 | 264 | 420 | - | 388 | 750 | 824 |
| Capex / Sales | 5.03% | 3.38% | 4.59% | - | 3.56% | 6.32% | 6.16% |
| Announcement Date | 4/14/20 | 4/12/21 | 4/15/22 | 4/24/23 | 4/24/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.81
CNY
Average target price
8.197
CNY
Spread / Average Target
+70.41%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.97% | 2.58B | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- 002044 Stock
- Financials Meinian Onehealth Healthcare Holdings Co., Ltd.
